Literature DB >> 6725496

Effects of labelling on income, work and social function among hypertensive employees.

M E Johnston, E S Gibson, C W Terry, R B Haynes, D W Taylor, A Gafni, J I Sicurella, D L Sackett.   

Abstract

Two hundred and thirty hypertensive Canadian steelworkers were followed for 5 years after screening and referral. Data on income, absenteeism and measures of work and social function were collected on these men and on a matched group of 230 normotensive employees. In the fifth year after screening, hypertensive employees earned an average of Can. $1093 less than normotensive employees despite similar incomes in the year before screening. This adverse effect on income was observed regardless of awareness of hypertension at the time of screening or compliance with treatment. Illness-related absenteeism among hypertensives rose in the year following screening and remained elevated for 4 years after screening. Normotensive and hypertensive employees reported similar levels of physical ability and psychological well-being. These findings need verification in other settings before inclusion in cost-effectiveness analyses of the management of hypertension.

Entities:  

Mesh:

Year:  1984        PMID: 6725496     DOI: 10.1016/0021-9681(84)90025-0

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  17 in total

1.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

2.  Essential hypertension: a sign in search of a disease.

Authors:  D Jennings; M G Netsky
Journal:  CMAJ       Date:  1991-04-15       Impact factor: 8.262

3.  Glomerular filtration rate: screening cannot be recommended on the basis of current knowledge.

Authors:  Catherine M Clase
Journal:  BMJ       Date:  2006-11-18

4.  Presymptomatic Diagnosis of Genetic Disorders: Is it worth the anxiety?

Authors:  T N Tannenbaum; E E Rosenberg
Journal:  Can Fam Physician       Date:  1991-02       Impact factor: 3.275

Review 5.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

6.  Cost of antihypertensive treatment: a point of view from India.

Authors:  H K Bali; I S Anand
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

7.  Polycystic ovarian syndrome: overdiagnosed and overtreated?

Authors:  Jane Wilcock; David Taylor
Journal:  Br J Gen Pract       Date:  2018-05       Impact factor: 5.386

8.  Early detection and treatment of hyperlipidemia: physician practices in Canada.

Authors:  T N Tannenbaum; J S Sampalis; R N Battista; E R Rosenberg; L Joseph
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

9.  Evaluation of public health preschool child developmental screening: the process and outcomes of a community program.

Authors:  D Cadman; L W Chambers; S D Walter; R Ferguson; N Johnston; J McNamee
Journal:  Am J Public Health       Date:  1987-01       Impact factor: 9.308

10.  Hepatitis C and poor quality of life: is it the virus or the patient?

Authors:  Ayman A Abdo
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.